Meningioma Doctors Abroad — Page 3

Professor Lee Jung Il is a lead neurosurgeon at Samsung Medical Center – one of South Korea's most prestigious hospitals.

• Specialises in Gamma Knife radiosurgery – a high-precision radiation treatment that targets brain tumours without incisions
• Serves as a senior consultant in the Brain Tumour Centre
• Focuses on non-invasive management for skull base meningioma cases
• Uses advanced imaging to treat tumours near critical brain structures

Professor Kwan Park is a lead neurosurgeon at Samsung Medical Center – one of South Korea's most prestigious specialist hospitals.

• Specialises in skull base surgery to treat complex tumours including meningioma
• Focuses on microsurgical resection to remove tumours while protecting surrounding brain tissue
• Practises at a major tertiary centre known for managing difficult neurological cases
• Treats international patients at Samsung's highly regarded neurosurgery department

Dr Elnur Sahibov is a specialist radiation oncologist at Emsey Hospital who focuses on targeted radiation therapy for intracranial tumours.

• Specialised in radiation oncology at Marmara University Faculty of Medicine
• Uses precise radiation delivery to treat meningiomas without open surgery
• Completed medical training through a prestigious English-language clinical programme
• Focuses on non-invasive techniques to preserve healthy brain tissue

The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.

Dr Shruti Kate trained at the world-renowned Tata Memorial Hospital, specialising in medical oncology for both solid tumours and paediatric cases.

• Practices at HCG Manavata Cancer Centre using immunotherapy for advanced stage tumours
• Expert in metronomic therapy – uses low-dose, frequent medication to control tumour growth
• Member of the European Society for Medical Oncology (ESMO)
• Received the World Conference on Lung Cancer travel award for her research
• Member of the International Association for the Study of Lung Cancer

Professor Sridhar P.S. is a specialist radiation oncologist at HCG Manavata Cancer Centre with over two decades of experience in treating tumours of the central nervous system.

• Specialises in precision radiotherapy for meningioma and other complex brain tumours
• Active member of the international Society for Neuro-Oncology
• Awarded a Diplomate of National Board in radiotherapy
• Focuses on targeted radiation to protect healthy brain tissue and reduce side effects
• Member of the Association of Radiation Oncology of India

Professor Engin is a seasoned radiation oncologist who served as director of oncology at several major medical centres, including Medicana Bursa.

• Completed a prestigious post-doctoral fellowship at Thomas Jefferson University in the United States
• Recognised with a research scholarship from the National Cancer Institute (NCI) in Bethesda
• Former Chairman of Radiation Oncology at Uludağ University Medical College
• Specialises in precise radiation therapy to manage tumours like meningiomas without invasive surgery
• Previously coordinated oncological sciences at the JCI-accredited Anadolu Medical Center

Professor Vadhiraja B. M. leads the radiotherapy department at Manipal Hospitals, focusing on high-precision treatment for complex tumours.

• Specialises in stereotactic radiosurgery (SRS) – uses high-dose radiation to treat brain tumours without open surgery
• Practises at Manipal Hospitals – part of India's second-largest healthcare network
• Focuses on precision-guided radiotherapy to preserve surrounding healthy brain tissue
• Applies clinical protocols for managing both benign and malignant tumours